Back to Search
Start Over
(+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload.
- Source :
-
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Jun 11; Vol. 29 (6), pp. 209. - Publication Year :
- 2024
-
Abstract
- Background: Nonalcoholic fatty liver disease (NAFLD) is a prevalent condition characterized by hepatic fat accumulation, often progressing to severe liver injury, for which approved treatments are currently lacking. This study explores the potential therapeutic impact of alpha-lipoic acid (ALA), a natural compound crucial in lipid metabolism, on NAFLD using an in vitro model.<br />Methods: HepG2 cells were treated with a palmitic acid:oleic acid (PA:OA) mixture, representing a cellular model of steatosis. Subsequent treatment with ALA at concentrations of 1 µM and 5 µM aimed to evaluate its effects on lipid content and metabolism. Real-time polymerase chain reaction (PCR), BODIPY staining, cytofluorimetric analysis, and lipidomics were used to assess gene expression, lipid droplet accumulation, and fatty acid profiles.<br />Results: Our results showed that ALA significantly reduced lipid droplets in PA:OA-treated HepG2 cells, with a concentration-dependent effect. Analysis of fatty acid profiles demonstrated a decrease in palmitic acid levels with ALA treatment, while oleic acid reduction was observed only at the higher concentration. Moreover, ALA modulated the expression of genes involved in cholesterol biosynthesis and low-density lipoprotein (LDL) metabolism, indicating a potential role in lipid homeostasis. Further insights into molecular mechanisms revealed that ALA modulated peroxisome proliferator activated receptors (PPARs), specifically PPAR-alpha and PPAR-gamma, involved in fatty acid metabolism and insulin sensitivity. Finally, ALA counteracted the overexpression of thermogenic genes induced by exogenous fatty acids, suggesting a regulatory role in energy dissipation pathways.<br />Conclusion: In conclusion, this study highlights ALA as a therapeutic agent in mitigating lipid accumulation and dysregulation in NAFLD.<br />Competing Interests: Given their role as Guest Editor, GLV had no involvement in the peer-review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Margaret O. James. The authors declare no other conflict of interest.<br /> (© 2024 The Author(s). Published by IMR Press.)
- Subjects :
- Humans
Hep G2 Cells
Gene Expression Regulation drug effects
Fatty Acids metabolism
PPAR gamma metabolism
Lipid Droplets metabolism
Lipid Droplets drug effects
PPAR alpha metabolism
PPAR alpha genetics
Uncoupling Protein 2 metabolism
Uncoupling Protein 2 genetics
Thioctic Acid pharmacology
Lipid Metabolism drug effects
Non-alcoholic Fatty Liver Disease metabolism
Non-alcoholic Fatty Liver Disease drug therapy
Non-alcoholic Fatty Liver Disease genetics
Oleic Acid pharmacology
Oleic Acid metabolism
Palmitic Acid pharmacology
Palmitic Acid metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2768-6698
- Volume :
- 29
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Frontiers in bioscience (Landmark edition)
- Publication Type :
- Academic Journal
- Accession number :
- 38940024
- Full Text :
- https://doi.org/10.31083/j.fbl2906209